Buy 2C-T-22 Cas 648957-48-6
Buy 2C-T-22 Cas 648957-48-6
2C-T-22, also known as 4-(2,2,2-trifluoroethylthio)-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine, 2C, and 2C-T-x families.[1][2] It is closely related to 2C-T-21 (the 4-(2-fluoroethylthio) analogue and 2C-T-21.5 (the 4-(2,2-difluoroethylthio) analogue).[1][2]
Use and effects
2C-T-22 was briefly described by Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) in the 2C-T-21 entry, but Shulgin only partially completed the chemical synthesis of 2C-T-22 and did not test it.[2] Subsequently, Daniel Trachsel completed the synthesis of 2C-T-22 and defined its dose as greater than 10 mg orally and its duration as approximately 6 hours.[1] A total dose of 5 mg plus 5 mg plus 6 mg produced the first signs of effects, but higher doses were not explored.[1][3] Hence, its precise dose range remains unknown.[4][1][3]
Interactions
Pharmacology
Pharmacodynamics
2C-T-22 shows affinity for the serotonin 5-HT2A receptor (Ki = 16–102 nM) and the serotonin 5-HT2C receptor (Ki = 28–151 nM).[1][5] It has been found to be a potent partial agonist of the serotonin 5-HT2A and 5-HT2B receptors.[5] Other receptor and target interactions have also been described.[5]
History
2C-T-22 was first described in the scientific literature by Shulgin in his book PiHKAL in 1991.[2] Subsequently, Trachsel described and completed the synthesis of 2C-T-22 in 2003[6] and he and his colleagues defined its properties in humans in 2013.[1][3]
Society and culture
Legal status
Canada
2C-T-22 is a controlled substance in Canada under phenethylamine blanket-ban language.[7]



Reviews
There are no reviews yet.